Transport
Dukes Health System LLC
Dukes Health System LLC was paid $8.87M by Medicaid between Jan 2018 and Nov 2024, across 98 billing codes. Its largest line is 99283, emergency room visit (moderate) — 30% of everything it billed.
33Billing provider infoDUKES HEALTH SYSTEM LLC
PERU, IN 46970
PERU, IN 46970
33aNPI1619920949assigned 05/18/2006
33bProvider typeAmbulance
28Total paid$8.87M
24GClaims194,329
24DCodes billed98
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ambulance providers in Indiana
Rank by total paid#3 of 85
Median peer was paid$457K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,516 | $286K | |
| 2019 | 20,787 | $748K | |
| 2020 | 24,735 | $898K | |
| 2021 | 30,737 | $1.44M | |
| 2022 | 39,436 | $2.06M | |
| 2023 | 40,437 | $2.13M | |
| 2024incomplete | 22,681 | $1.31M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 30% | 16,571 | 13,196 | $2.68M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 12,063 | 8,870 | $1.84M |
| 71045 | Radiologic examination, chest; single view | 7.7% | 6,127 | 4,530 | $679K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 6.5% | 6,701 | 5,057 | $580K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.0% | 4,498 | 3,147 | $529K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.7% | 6,089 | 4,005 | $331K |
| A0425 | Ground mileage, per statute mile | 3.6% | 11,597 | 7,652 | $321K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.4% | 3,848 | 2,906 | $216K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 1,502 | 1,223 | $192K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 1.6% | 1,404 | 1,012 | $139K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 5,426 | 4,127 | $134K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 17,154 | 11,751 | $91K |
86 more codes
| 80053 | Comprehensive metabolic panel | <1% | 11,472 | $82K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,681 | $77K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 420 | $73K |
| 36415 | Collection of venous blood by venipuncture | <1% | 26,139 | $70K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 774 | $67K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,857 | $54K |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 668 | $54K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,832 | $53K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,769 | $51K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 149 | $48K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 679 | $41K |
| 84484 | <1% | 5,479 | $40K | |
| 80050 | General health panel | <1% | 356 | $35K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,096 | $35K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 882 | $34K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 511 | $30K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,124 | $27K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 599 | $22K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 148 | $20K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,481 | $16K |
| 81001 | <1% | 4,957 | $15K | |
| 85610 | <1% | 4,196 | $14K | |
| 83605 | <1% | 1,715 | $13K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,364 | $13K |
| 83690 | <1% | 2,906 | $13K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,077 | $10K |
| 83880 | <1% | 606 | $10K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 73 | $10K |
| 94760 | <1% | 269 | $9K | |
| 80061 | Lipid panel | <1% | 1,177 | $9K |
| 87430 | <1% | 685 | $8K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,125 | $6K |
| 85730 | <1% | 1,377 | $6K | |
| 83735 | <1% | 1,190 | $6K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 422 | $6K |
| 86140 | <1% | 1,187 | $5K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 75 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 371 | $5K |
| 99218 | <1% | 18 | $4K | |
| 85652 | <1% | 1,507 | $3K | |
| 87400 | <1% | 718 | $3K | |
| 82077 | <1% | 245 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 233 | $3K |
| 81025 | <1% | 393 | $3K | |
| 82607 | <1% | 287 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 475 | $2K |
| 82746 | <1% | 251 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 52 | $2K |
| 85379 | <1% | 302 | $2K | |
| 86141 | <1% | 207 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 388 | $1K |
| G0378 | Hospital observation service, per hour | <1% | 16 | $1K |
| 85027 | <1% | 246 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,041 | $996.65 |
| 80076 | <1% | 461 | $982.45 | |
| 87807 | <1% | 85 | $969.40 | |
| 81003 | <1% | 533 | $919.47 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 43 | $880.58 |
| 84702 | <1% | 75 | $758.96 | |
| 73630 | <1% | 21 | $592.20 | |
| 86850 | <1% | 103 | $451.98 | |
| 87040 | <1% | 92 | $419.45 | |
| 84100 | <1% | 142 | $372.82 | |
| J2704 | Injection, propofol, 10 mg | <1% | 46 | $347.70 |
| 82150 | <1% | 106 | $318.82 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 205 | $229.13 |
| 86901 | <1% | 104 | $198.85 | |
| 86900 | <1% | 104 | $195.86 | |
| 84481 | <1% | 13 | $193.96 | |
| 86803 | <1% | 15 | $170.51 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $158.55 |
| 87088 | <1% | 112 | $156.12 | |
| 82550 | <1% | 32 | $116.22 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 503 | $114.74 |
| 84439 | <1% | 13 | $93.86 | |
| 82248 | <1% | 47 | $92.92 | |
| 82043 | <1% | 19 | $86.70 | |
| 86701 | <1% | 14 | $66.99 | |
| 84703 | <1% | 12 | $63.47 | |
| 82570 | <1% | 15 | $56.98 | |
| 85651 | <1% | 61 | $48.29 | |
| 86592 | <1% | 13 | $38.43 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 30 | $34.25 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 26 | $10.13 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 12 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.